ELMD (Electromed) Beta: 1.1563 (As of Jun. 25, 2026)


ELMD Electromed Inc ELMD
91 GF Score
Price $39.99
GF Value $25.15
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Electromed Beta?

Electromed ELMD +2.21% 91 Beta is 1.1563 as of Jun. 25, 2026. GuruFocus rates ELMD with a GF Score™ of 91/100 and a GF Value™ of $25.15 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-25), Electromed's Beta is 1.1563.


Electromed  (AMEX:ELMD) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Electromed Beta Related Terms


Electromed Beta Historical Data

* Premium members only.

The historical data trend for Electromed's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Electromed Beta Chart

Electromed Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.71 0.69 0.16 0.02 0.01

Electromed Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.29 0.01 0.24 0.35 0.82

ELMD vs MASS, SI, CV: Beta Comparison

For the Medical Devices subindustry, Electromed's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Electromed Beta vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Electromed's Beta distribution charts can be found below:

* The bar in red indicates where Electromed's Beta falls into.


ELMD
91GF Score
Electromed Inc ELMD
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Electromed Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.1563 mean?
Electromed (ELMD) has a Beta of 1.1563 as of Jun. 25, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Electromed and its competitors.
Is Electromed's Beta too high?
Electromed's current Beta is 1.1563. Overall, Electromed has a GF Score™ of 91/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Electromed's Beta compare to MASS and SI?
Electromed's Beta of 1.1563 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Electromed and its competitors. Electromed's current Beta is 1.1563. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Electromed stock overvalued right now?
Based on GuruFocus' analysis, Electromed (ELMD) is currently considered Significantly Overvalued. The stock's GF Value™ is $25.15, compared to a current price of $39.99 — trading 59% above its estimated fair value. The current Beta is 1.1563. Electromed's overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Electromed (ELMD), the current Beta is 1.1563 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Electromed (ELMD) Overvalued in 2026?

Based on GuruFocus' analysis, Electromed stock appears to be overvalued. The current stock price of $39.99 is trading 59% above its estimated GF Value™ of $25.15. GuruFocus considers Electromed to be Significantly Overvalued.

Key valuation signals for ELMD:

  • Beta: 1.1563
  • GF Value™: $25.15 vs. price of $39.99 (59% above fair value)
  • GF Score™: 91/100 with 5 warning signs

No single metric tells the full story. See the ELMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Electromed Business Description

Address 500 Sixth Avenue NW, New Prague, MN, USA, 56071
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
91GF Score

Get the complete analysis for ELMD

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$39.99
Price
$25.15
GF Value